Convertible Notes Payable (Details) - DIAMIR BIOSCIENCES CORP. [Member] - USD ($) |
9 Months Ended | 10 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|---|
Feb. 28, 2026 |
Mar. 31, 2026 |
May 31, 2024 |
May 31, 2025 |
Feb. 28, 2025 |
|
| Convertible Notes Payable [Line Items] | |||||
| Additional borrowings | $ 150,000 | ||||
| Interest rate | 4% | ||||
| Effective interest rate | 9.50% | ||||
| Borrowings amount | $ 100,000 | ||||
| Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ 1.8 | $ 5.87 | |||
| Additional borrowing | $ 35,063 | ||||
| Convertible Notes Payable [Member] | |||||
| Convertible Notes Payable [Line Items] | |||||
| Debt discount | $ 60,732 | $ 105,178 | $ 96,332 | ||
| Effective interest rate | 10.00% | 10.00% | |||
| Debt interest rate | 4.00% | 10.00% | |||
| Founders [Member] | Convertible Notes Payable [Member] | |||||
| Convertible Notes Payable [Line Items] | |||||
| Debt discount | $ 12,694 | ||||
| Effective interest rate | 10.00% | 9.50% | |||
| Additional borrowings | $ 200,000 | ||||
| Debt instrument principal amount | $ 300,000 |
| X | ||||||||||
- Definition Payment to Discounts on Note Payable to Founder. No definition available.
|
| X | ||||||||||
- Definition Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The price per share of the conversion feature embedded in the debt instrument. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Description of any adjustments made to the stated rate to determine the effective rate. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after accumulated amortization, of debt discount. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from a borrowing supported by a written promise to pay an obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|